Clinical Trial Update: The ENDEAVOR Pharmacokinetic (PK) Registry: The Medtronic Endeavor Drug Eluting Coronary Stent System [NA]

View source ↗

Summary

A completed pharmacokinetic registry evaluating the Endeavor drug-eluting coronary stent system by Medtronic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Endeavor Drug Eluting Coronary Stent System

Snippet

Sponsor: Medtronic Vascular | Conditions: Coronary Artery Disease | NA | Status: COMPLETED